The American Century Quality Diversified International ETF (QINT) offers diversified exposure to non-US equities, with notable holdings like Novartis, Hermes, and Sony. While the fund provides access to innovative and market-leading companies, rising P/E ratios driven by declining earnings are raising valuation concerns. Despite diversification, the analyst suggests that many top holdings appear overvalued at current levels, making the ETF less attractive from a valuation perspective and indicating a preference for undervalued opportunities elsewhere.
The American Century Quality Diversified International ETF (QINT) provides broad exposure to non-US equities, featuring prominent innovative and market-leading companies such as Novartis, Hermes, and Sony within its top holdings. While the quality of these underlying companies is acknowledged as attractive, a significant concern arises from their valuation. Specifically, rising price-to-earnings (P/E) ratios, reportedly driven by declining earnings, suggest that many of QINT's top holdings are currently overvalued. This overvaluation renders the ETF less appealing from a valuation standpoint at its present levels, despite its diversification benefits. The analyst expresses a bullish view on the individual companies but maintains a cautious stance on QINT itself due to these prevailing overvaluation risks, indicating a preference for seeking undervalued investment opportunities elsewhere. The overall sentiment towards QINT is moderately negative, reflecting these valuation concerns.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment